The Value of Reporting Therapeutic Ineffectiveness as an Adverse Drug Reaction.
- Published in:
- Drug Safety, 2000, v. 23, n. 2, p. 95, doi. 10.2165/00002018-200023020-00001
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 2000 AND VI 23 AND IP 2
Results: 6
1
2
Post-transplant malignancy: the role of immunosuppression.
- Published in:
- 2000
- By:
- Publication type:
- journal article
3
A Risk-Benefit Assessment of Injections of Hyaluronan and its Derivatives in the Treatment of Osteoarthritis of the Knee.
- Published in:
- Drug Safety, 2000, v. 23, n. 2, p. 115, doi. 10.2165/00002018-200023020-00003
- By:
- Publication type:
- Article
4
A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections.
- Published in:
- 2000
- By:
- Publication type:
- journal article
5
Drug-Induced Respiratory Disorders: Incidence, Prevention and Management.
- Published in:
- Drug Safety, 2000, v. 23, n. 2, p. 143, doi. 10.2165/00002018-200023020-00005
- By:
- Publication type:
- Article
6
A Survey on Factors that Could Affect Adverse Drug Reaction Reporting According to Hospital Pharmacists in Great Britain.
- Published in:
- Drug Safety, 2000, v. 23, n. 2, p. 165, doi. 10.2165/00002018-200023020-00006
- By:
- Publication type:
- Article